Skip to content

Economic Evaluation

Principles of Cost-Benefit Analysis, Cost-Utility Analysis, CEA, Cost-Consequences Analysis and Cost Analysis; techniques of CBA in health and health care; techniques of CUA and CEA in health and health care; techniques of CCA and CA in health and health care; decision theoretical approaches; pharmacoeco- nomics; economic evaluation of clinical devices; economic evaluation of public health interventions; outcome measures and their interpretation; evidence, efficacy and effectiveness; Health Technology Assessment; study design; risk and uncer- tainty; discounting; sensitivity analyses; modeling; systematic reviews and meta-analyses.

Bayesian evidence synthesis and bootstrapping for trial-based economic evaluations: comfortable bed fellows?

By Mohsen Sadatsafavi and Stirling Bryan In economic evaluation of health technologies, evidence synthesis is typically about quantification of the evidence in terms of parameters. Bootstrapping is a non-parametric inferential method in trial-based economic evaluations. On the surface the two… Read More »Bayesian evidence synthesis and bootstrapping for trial-based economic evaluations: comfortable bed fellows?

Bad science in health economics: complementary medicine, costs and mortality

By Chris Sampson, David Whitehurst and Andrew Street In December 2012, an article was published in The European Journal of Health Economics with the title ‘Patients whose GP knows complementary medicine tend to have lower costs and live longer’. We… Read More »Bad science in health economics: complementary medicine, costs and mortality

The potential of the super QALY to reconcile the key contentions in health economics

Economics is largely about trade-offs and compromise. Academics study the former but don’t often engage in the latter. In health economics, as in other fields, a key trade-off is between equity and efficiency. We’ve been studying this for a.very.long.time. Despite this, as… Read More »The potential of the super QALY to reconcile the key contentions in health economics

Cannabis and asbestos: The cost-effectiveness of prohibition as health policy

The aim of a health intervention is generally to cause a cost-effective increase to some normative outcome such as by reducing mortality, increasing productivity and so forth. Often policy makers want to encourage or discourage certain behaviours by using incentives… Read More »Cannabis and asbestos: The cost-effectiveness of prohibition as health policy